Trials / Completed
CompletedNCT06477276
Amygdala TIS for Depression
A Multicenter, Randomized, Controlled, Double-Blind Trial on the Efficacy and Safety of Amygdala Temporal Interference Stimulation for the Treatment of Depression.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The current investigation employs a directed neuromodulation technique, specifically targeting the right amygdala, to ascertain its therapeutic efficacy in managing depressive episodes. The intervention's safety and efficacy will be evaluated using an assessment incorporating depressive symptomatology, cognitive abilities, and daily functions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nervio-X | An 8-channel TIS device developed by NEURODOME Corporation. |
Timeline
- Start date
- 2024-07-24
- Primary completion
- 2025-05-01
- Completion
- 2025-05-01
- First posted
- 2024-06-27
- Last updated
- 2025-06-19
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06477276. Inclusion in this directory is not an endorsement.